239 related articles for article (PubMed ID: 8112040)
1. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
Polak J; Della Latta P; Blackburn P
Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
LaPlante KL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
[TBL] [Abstract][Full Text] [Related]
3. Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.
Kiri N; Archer G; Climo MW
Antimicrob Agents Chemother; 2002 Jun; 46(6):2017-20. PubMed ID: 12019130
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
Kusuma CM; Kokai-Kun JF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.
Komatsuzawa H; Suzuki J; Sugai M; Miyake Y; Suginaka H
J Antimicrob Chemother; 1994 Jun; 33(6):1155-63. PubMed ID: 7928809
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains.
Rochon-Edouard S; Pestel-Caron M; Lemeland JF; Caron F
Antimicrob Agents Chemother; 2000 Nov; 44(11):3055-60. PubMed ID: 11036022
[TBL] [Abstract][Full Text] [Related]
7. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
Graham S; Coote PJ
J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
[TBL] [Abstract][Full Text] [Related]
8. Additive, indifferent and antagonistic effects in combinations of epigallocatechin gallate with 12 non-beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Hu ZQ; Zhao WH; Yoda Y; Asano N; Hara Y; Shimamura T
J Antimicrob Chemother; 2002 Dec; 50(6):1051-4. PubMed ID: 12461032
[TBL] [Abstract][Full Text] [Related]
9. Activity of clavulanate-potentiated penicillins against methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Griffin K; Witte W; Svacina W
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():49-54. PubMed ID: 2606819
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
Climo MW; Ehlert K; Archer GL
Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
[TBL] [Abstract][Full Text] [Related]
11. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
[TBL] [Abstract][Full Text] [Related]
12. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
Becker SC; Foster-Frey J; Donovan DM
FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
[TBL] [Abstract][Full Text] [Related]
13. Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.
Zygmunt WA; Harrison EF; Browder HP; Tavormina PA
Appl Microbiol; 1968 Aug; 16(8):1174-8. PubMed ID: 5187926
[TBL] [Abstract][Full Text] [Related]
14. Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant
Fang Y; Kirsch JR; Li L; Brooks SA; Heim S; Tan C; Eszterhas S; Cheng HD; Zhao H; Xiong YQ; Griswold KE
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318001
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF
J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520
[TBL] [Abstract][Full Text] [Related]
17. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
Placencia FX; Kong L; Weisman LE
Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
[TBL] [Abstract][Full Text] [Related]
18. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
[TBL] [Abstract][Full Text] [Related]
19. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus.
Liu IX; Durham DG; Richards RM
J Pharm Pharmacol; 2000 Mar; 52(3):361-6. PubMed ID: 10757427
[TBL] [Abstract][Full Text] [Related]
20. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
